This study explores the mechanisms of YFJDT using bioinformatics, xenograft models, and A549 cells, demonstrating that YFJDT downregulates HIF1A, promotes ferroptosis, and inhibits epithelial‐mesenchymal transition (EMT) and vasculogenic mimicry (VM), suggesting novel therapeutic strategies for lung cancer. This evidence concerns the gene HIF1A and lung cancer.